Revelation Biosciences Inc (NASDAQ:REVB) price on Thursday, December 26, rose 17.10% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.35.
A look at the stock’s price movement, the close in the last trading session was $0.30, moving within a range at $0.323 and $0.3778. Turning to its 52-week performance, $25.26 and $0.28 were the 52-week high and 52-week low respectively. Overall, REVB moved -52.61% over the past month.
Revelation Biosciences Inc’s market cap currently stands at around $2.94 million, with investors looking forward to this quarter’s earnings report slated for in January.
Turning to the stock’s technical picture we see that short term indicators suggest on average that REVB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend REVB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
REVB’s current price about -21.94% and -48.73% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.88, while 7-day volatility ratio is 20.23% and 16.14% in the 30-day chart. Further, Revelation Biosciences Inc (REVB) has a beta value of 0.21, and an average true range (ATR) of 0.07.
If we refocus on Revelation Biosciences Inc (NASDAQ:REVB), historical trading data shows that trading volumes averaged 0.84 over the past 10 days and 1.07 million over the past 3 months. The company’s latest data on shares outstanding shows there are 8.36 million shares.
The 0.07% of Revelation Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 1.18% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.13 million on 2024-11-29, giving us a short ratio of 0.11. The data shows that as of 2024-11-29 short interest in Revelation Biosciences Inc (REVB) stood at 293.0 of shares outstanding, with shares short rising to 41245.0 registered in 2024-10-31. Current price change has pushed the stock -97.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the REVB stock continues to rise going into the next quarter.
